Anticancer Drugs Market: Increasing Lung Cancer Cases Leading to Growing Sales

Published on : Nov 27, 2018

Albany, New York, November 27, 2018: Anticancer drug, also called as antineoplastic drug, has garnered attention like never before. Some of the anticancer drugs incorporate of antimetabolites, alkylating agents, natural products and hormones. Determination of the usage of specific anticancer drugs hinges upon location and types of the cancer, its impact and if radiation therapy or surgery should be used. World Health Organization deduced that by 2030 the cases of global cancer deaths is feasible to rise by 45%. These assimilations are according to the report titled “Global Market Study on Anticancer Drugs: Targeted Therapy Drug Class Anticipated to Exhibit Highest Revenue Contribution Through 2026” which has been recently added to the repository of Market Research Hub (MRH). The study highlights the key factors that are leading to a growth in anticancer drugs market globally.

The rampant cancer cases has spurred the anticancer drugs market. Meanwhile, mortality rate from cancer is estimated to surpass thirteen million in 2030 and 80% surge in the new cancer cases in low-income countries is twice the rate estimated in high-income countries by 2030.

New drug development has received praise from all corners which could be attributed to the obstacles lingering in the treatment of cancers such as small cell lung cancer. Moreover, new drug pipeline has garnered a major boost owing to the augmentation in the expenditures of research and development and escalation in the number of clinical trials. Anticancer treatment market is set to be bolstered due to the optimism associated with the survival rate of cancers. Having said that, lung cancer is projected to woo the market as it is most rampant disease and the survival rate is gloomy. Besides, the prevalence of diagnostic tests such as nuclear medicine, computed tomography are set to further strengthen the anticancer drugs market.

Anticancer Drugs Market: Report Content

The assessment of this report provides an exhaustive analysis on anticancer drugs market. Further, the report also delineates the different types of cancer with regards to prominent regions. Moreover, the report also delves into the drivers, opportunities, restraints, trends and opportunities in the anticancer drugs market. Besides, opportunity analysis gives clients to assimilate the market with coherent decision making insights.

Regionally, the market has been assessed on the basis of drug class, indications and distribution channel and region. The regions covered in the report are North America, Latin America, Europe, Asia Pacific excluding Japan, Middle East and Africa and Japan.

The report begins with the executive summary followed by the market definition, macro-economic factors and opportunity analysis. The report delves into the market background and analyzes the competitive landscapes. Furthermore, the report embodies epidemiology, pipeline analysis and mergers and analysis.

Anticancer Drugs Market: Research Methodology

An exhaustive research methodology has been embraced with regards to providing a research approach incorporating of secondary and primary research. The insights in the report is the result of an in-depth secondary research, primary interviews and in-house reviews by panel of experts. In house model has been adopted to estimate the anticancer drugs market value.

The secondary research incorporates company websites, SEC filings and presentations by investors, industry white paper and statistical database. Besides, the primary research embodies face to face interviews, phonic interviews and e-mail interaction. To provide the readers with authentic report, a panel of expert analyzes the data collected from various sources. To deduce the market size, per capital healthcare expenditure, disposable income, new facial rejuvenation products and approvals for new products have been considered.

Request a Sample with TOC in a PDF format :

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top